Morphea secondary to interferon betai B injection: A case and review of the literature

Basit Öğe Kaydı
dc.contributor.authorÖzlü, Emin
dc.contributor.authorKaradağ, Ayşe Serap
dc.contributor.authorAkdeniz, Necmettin
dc.contributor.authorUzunçakmak, Tuğba Kevser
dc.contributor.authorZemheri, Ebru
dc.contributor.authorÖzkanlı, Şeyma
dc.date.accessioned2020-04-30T13:32:48Z
dc.date.available2020-04-30T13:32:48Z
dc.date.issued2019
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionPubMed ID: 31046913en_US
dc.description.abstractInterferon beta (IFNß) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNß is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNßlb injection is very rare. © 2019, Dermatology Online Journal. All rights reserved.en_US
dc.identifier.issn1087-2108
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12684/445
dc.identifier.volume25en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherDermatology Online Journalen_US
dc.relation.ispartofDermatology Online Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInterferon beta; Morphea; Side effectsen_US
dc.titleMorphea secondary to interferon betai B injection: A case and review of the literatureen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu